152 related articles for article (PubMed ID: 21999608)
1. QSAR studies on HIV-1 protease inhibitors using non-linearly transformed descriptors.
Saranya N; Selvaraj S
Curr Comput Aided Drug Des; 2012 Mar; 8(1):10-49. PubMed ID: 21999608
[TBL] [Abstract][Full Text] [Related]
2. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
[TBL] [Abstract][Full Text] [Related]
3. Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity.
Halder AK; Jha T
Bioorg Med Chem Lett; 2010 Oct; 20(20):6082-7. PubMed ID: 20832304
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of conceptual DFT descriptors and docking scores on the QSAR models of HIV protease inhibitors.
Srivastava HK; Choudhury C; Sastry GN
Med Chem; 2012 Sep; 8(5):811-25. PubMed ID: 22741804
[TBL] [Abstract][Full Text] [Related]
5. Finding the structural requirements of diverse HIV-1 protease inhibitors using multiple QSAR modelling for lead identification.
Halder AK
SAR QSAR Environ Res; 2018 Nov; 29(11):911-933. PubMed ID: 30332922
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors.
Khedkar VM; Ambre PK; Verma J; Shaikh MS; Pissurlenkar RR; Coutinho EC
J Mol Model; 2010 Jul; 16(7):1251-68. PubMed ID: 20069323
[TBL] [Abstract][Full Text] [Related]
7. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
[TBL] [Abstract][Full Text] [Related]
8. Identifying the molecular mechanics and binding dynamics characteristics of potent inhibitors to HIV-1 protease.
Li D; Liu MS; Ji B; Hwang KC; Huang Y
Chem Biol Drug Des; 2012 Sep; 80(3):440-54. PubMed ID: 22621379
[TBL] [Abstract][Full Text] [Related]
9. Fragment-Based QSAR and Structural Analysis of a Series of Hydroxyethylamine Derivatives as HIV-1 Protease Inhibitors.
Ferreira LG; Andricopulo AD
Comb Chem High Throughput Screen; 2015; 18(5):464-75. PubMed ID: 25961662
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
[TBL] [Abstract][Full Text] [Related]
11. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
Fatemi MH; Heidari A; Gharaghani S
J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
[TBL] [Abstract][Full Text] [Related]
12. Development of anti-HIV activity models of lysine sulfonamide analogs: a QSAR perspective.
Muthukumaran R; Sangeetha B; Amutha R; Mathur PP
Curr Comput Aided Drug Des; 2012 Mar; 8(1):70-82. PubMed ID: 21999609
[TBL] [Abstract][Full Text] [Related]
13. A priori molecular descriptors in QSAR: a case of HIV-1 protease inhibitors. II. Molecular graphics and modeling.
Kiralj R; Ferreira MM
J Mol Graph Model; 2003 Jun; 21(6):499-515. PubMed ID: 12676237
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 protease inhibitors: a comparative QSAR analysis.
Kurup A; Mekapati SB; Garg R; Hansch C
Curr Med Chem; 2003 Sep; 10(17):1679-88. PubMed ID: 12871116
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship of some HIV-1 protease inhibitors: a Fujita-Ban type analysis.
Mekapati SB; Sivakumar R; Gupta SP
J Enzyme Inhib; 2001; 16(3):185-97. PubMed ID: 11697040
[TBL] [Abstract][Full Text] [Related]
16. Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
Ahmed L; Rasulev B; Turabekova M; Leszczynska D; Leszczynski J
Org Biomol Chem; 2013 Sep; 11(35):5798-808. PubMed ID: 23900343
[TBL] [Abstract][Full Text] [Related]
17. Revealing interaction mode between HIV-1 protease and mannitol analog inhibitor.
Yan GW; Chen Y; Li Y; Chen HF
Chem Biol Drug Des; 2012 Jun; 79(6):916-25. PubMed ID: 22296911
[TBL] [Abstract][Full Text] [Related]
18. Computational analysis of HIV-1 protease protein binding pockets.
Ko GM; Reddy AS; Kumar S; Bailey BA; Garg R
J Chem Inf Model; 2010 Oct; 50(10):1759-71. PubMed ID: 20925403
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors.
Heidari A; Fatemi MH
Chem Biol Drug Des; 2017 Jun; 89(6):918-931. PubMed ID: 27933723
[TBL] [Abstract][Full Text] [Related]
20. Structure based prediction of binding affinity of human immunodeficiency virus-1 protease inhibitors.
Kulkarni SS; Kulkarni VM
J Chem Inf Comput Sci; 1999; 39(6):1128-40. PubMed ID: 10614027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
